தடுப்பூசி இயக்கி கட்டம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தடுப்பூசி இயக்கி கட்டம் . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தடுப்பூசி இயக்கி கட்டம் Today - Breaking & Trending Today

DNA Special: Why it is important for more Indians to get vaccinated to beat spike in COVID-19 cases


DNA Special: Why it is important for more Indians to get vaccinated to beat spike in COVID-19 cases
India is reeling under the second wave of COVID-19 and only 4 per cent of India s total population has been vaccinated so far.
Share
Updated: Apr 2, 2021, 06:37 AM IST
India is reeling under the second wave of COVID-19 and according to the Ministry of Health and Family Welfare (MoHFW), India recorded 72,330 new confirmed cases of Covid-19 in the past 24 hours. India also reported 459 more deaths and another 40,382 hospital discharges in the last 24 hours, as per the health ministry data on Thursday (April 1).
Vaccinations for people above the age of 45 years also began in India on Thursday. People were quite upbeat about the vaccination drive and came in huge numbers to get inoculated. ....

United States , United Kingdom , Ministry Of Health , United Arab Emirates , Saudi Arabia , Union Territories , Family Welfare , Covid 19 , Covid 19 Pandemic , Corona Virus , Covid Cases , Coronavirus Cases , Covid Vaccination , Coronavirus Vaccination , Vaccination Drive Phase 2 , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , அமைச்சகம் ஆஃப் ஆரோக்கியம் , ஒன்றுபட்டது அரபு அமீரகங்கள் , சவுதி அரேபியா , தொழிற்சங்கம் பிரதேசங்கள் , குடும்பம் நலன்புரி , கொரோனா வைரஸ் , தடுப்பூசி இயக்கி கட்டம் ,

Covaxin demonstrates 81% efficacy, says Bharat Biotech on Phase 3 results


Covaxin demonstrates 81% efficacy, says Bharat Biotech on Phase 3 results
Covaxin is one of two Covid vaccines that was granted emergency use approval in the country in early January.
File Photo
Updated: Mar 3, 2021, 07:44 PM IST
Bharat Biotech s coronavirus vaccine Covaxin demonstrated an interim efficacy of 81% against COVID-19, the company announced on Wednesday while releasing the results of Phase 3 clinical trials.
“Today is an important milestone in vaccine discovery, for science and our fight against coronavirus. With today’s results from our Phase 3 clinical trials, we have now reported data on our Covid-19 vaccine from Phase 1, 2, and 3 trials involving around 27,000 participants,” said Dr Kirishna Ella, Chairman and Managing Director of Bharat Biotech. ....

Andhra Pradesh , United Kingdom , Kirishna Ella , National Institute Of Virology , India Institute , Indian Council Of Medical Research , Bharat Biotech , Managing Director , Indian Council , Medical Research , National Institute , Drugs Controller General , Minister Narendra Modi , All India Institute Of Medical Science , Covid 19 , Corona Virus , Vaccination Drive Phase 2 , Bharat Biotech Covaxin , ஆந்திரா பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , கிரீஷின எல்லா , தேசிய நிறுவனம் ஆஃப் வைராலஜி , இந்தியா நிறுவனம் , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , பாரத் பயோடெக் , நிர்வகித்தல் இயக்குனர் ,